Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Glioblastoma Market Share

ID: MRFR//6835-CR | 133 Pages | Author: Kinjoll Dey| September 2019

Raman and NIR (near-infrared) spectroscopy are strong chemical analysis methods utilized in many industries worldwide. Market share positioning tactics of NIR and Raman spectroscopy solution providers are crucial to their success in the highly competitive analytical instrument industry.
Adding capabilities to NIR and Raman spectroscopy is a crucial method. These technologies are being developed to expand their use beyond the pharmaceutical and food industries. The idea is to integrate these technologies into developing disciplines including environmental monitoring, materials research, and healthcare. Business may acquire greater market share and serve more diversified clients by expanding their application range.
Using spectroscopic systems' adaptability and flexibility, another option under discussion, may solve the issue effectively. Modular solutions that may be customized for a certain sector or research allow organizations to satisfy more consumer demands. This allows firms to meet more customer needs. This technique increases technological flexibility and attracts clients seeking personalized solutions. This keeps the company competitive in the market.
Integrate complementary technology to strategically position oneself in the market. To offer complete answers, organizations often blend NIR and Raman spectroscopy with other analytical methods or equipment. Spectroscopy combined with imaging, chromatography, or artificial intelligence for enhanced data processing is one example. Integrations usually increase value, which boosts market share.
Pricing is crucial to market competitiveness. These firms have deliberately focused on cost-effectiveness to provide high-quality NIR and Raman spectroscopy solutions at competitive pricing. This technique increases market share by attracting cost-conscious clients. This applies particularly in financially constrained businesses.
Rigorous research and development and continuous innovation are crucial to market share positioning. Companies engage in NIR and Raman spectroscopy system development to improve performance, sensitivity, and usability. Being technologically advanced gives you an advantage. Customers seeking unique analytical solutions will benefit from this edge.
Successful companies in a specific field generally utilize a global growth strategy, which involves strategic collaborations and tapping into emerging markets. A strong worldwide presence and collaboration with local partners allow enterprises to access a variety of markets and capitalize on local knowledge. This strategy helps increase market share and modify goods to meet local needs.
A strategic approach that incorporates extensive training and user education may increase adoption. Enterprises work to teach their audience about NIR and Raman spectroscopy and how to use it. This maximizes technology utilization and builds client loyalty, which boosts market share.
Excellent customer service is crucial to market positioning. Businesses that prioritize customer satisfaction are more likely to build solid client relationships because they provide timely assistance and maintenance. Repeat business and strong word-of-mouth recommendations help maintain and grow market share. This generates repeat business.
Companies seeking to lead near-infrared and Raman spectroscopy are ensuring their technologies meet international standards. This is because environmental sustainability and regulatory compliance are becoming more important. These firms may improve their image by following the law and supporting green initiatives. This may attract clients that prioritize sustainability in their business operations.

Glioblastoma Market Highlights:

Glioblastoma Market Trends

Glioblastoma Market Analysis

Glioblastoma Market Share

Glioblastoma Companies

Global Glioblastoma Market Overview

Glioblastoma Market is expected to register a CAGR of 7.60% to reach USD 2416.33 million by 2030. Glioblastoma is a type of brain tumor.The increasing occurrences of glioblastoma, a type of brain tumor, coupled with extensive research in glioblastoma treatment, and the rising adoption of chemotherapy are expected to fuel the growth of the glioblastoma market. However, the high cost of drugs and the failure of drug candidates in clinical trial phases are anticipated to hamper the market growth.

Glioblastoma Market Trends

The increasing incidence rate of glioblastoma is expected to fuel the growth of the glioblastoma market. According to the statistics published in 2017 by the National Centre for Biotechnology Information (NCBI), glioblastoma has an incidence rate of 3.19 per 100,000 persons in the US. The growing prevalence indirectly increases the healthcare expenditure of the people as well as the government. This motivates the players operating in the market to come up with alternatives for the treatment of glioblastoma. Thus, this is likely to fuel the growth of the global glioblastoma market during the forecast period.

Glioblastoma Global Market Share, by End User, 2018 (%)

Source: MRFR Analysis

Glioblastoma Market Segment Insights

The global glioblastoma market has been segmented by type, treatment, and end user. The market, based on type, has been bifurcated into primary glioblastoma and secondary glioblastoma. Based on treatment, the glioblastoma market has been segregated into surgical procedure, radiation therapy, chemotherapy, and others. The global glioblastoma market, based on end user, has been divided into hospitals, specialty clinics and centers, and others. The specialty clinics and centers held a share of 36.8% in 2018.

Western Europe Glioblastoma Market Share, (%)

Source: MRFR Analysis

Glioblastoma Regional Insights

The glioblastoma global market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to dominate the global glioblastoma industry. The growth in this region can be attributed to the increased cases of glioblastoma and brain tumors. Moreover, the approval of drugs helps in maximizing the growth of the market in this region.

Europe held a substantial share in the global glioblastoma market. This can be attributed to a large number of clinical trials in the region. For instance, Merck KGaA along with Vaximm GmbH is involved in Phase I and II trials to evaluate the efficacy and safety of VXM01 in combination with Avelumab in patients with resectable and non-resectable progressive glioblastoma following tumor resection and radio-chemotherapy containing temozolomide.

Asia-Pacific is estimated to be the fastest-growing region in the global market. The rise in the improved healthcare infrastructure promises a high level of research on the treatment of glioblastoma in the region.

The glioblastoma market in the Middle East & Africa is expected to witness a modest market growth rate from 2019 to 2025. The Middle East would lead the market growth in this region. Rising awareness regarding health and availability of new treatment methods are expected to drive the market growth during the assessment period.

Key Players

The prominent players in the global glioblastoma market are F. Hoffmann-La Roche Ltd (Switzerland), Arbor Pharmaceuticals, LLC (US), Merck & Co., Inc. (US), Sun Pharmaceutical Industries Ltd (India), Amgen Inc. (US), and Teva Pharmaceutical Industries Ltd (Israel).

Some of the key strategies followed by players operating in the global glioblastoma market were innovation, product development, and acquisition & mergers.

In May 2019 Merck entered into a definitive agreement to acquire Peloton Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company, focused on the development of novel small molecule therapeutic candidates targeting hypoxia-inducible factor-2α (HIF-2α) for the treatment of patients with cancer and other non-oncology diseases.

In January 2018 Amgen and Allergan PLC received the approval by the European Commission (EC) for the marketing authorization of MVASI for the treatment of glioblastoma as well as certain types of cancers.

In November 2016 Sun Pharma acquired Biosintez, a Russian pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical products.

Glioblastoma Market Segmentation

Glioblastoma Type Outlook

Primary Glioblastoma

Secondary Glioblastoma

Glioblastoma Treatment Outlook

Surgical Procedure

Radiation Therapy

Chemotherapy

Others

Glioblastoma End User Outlook

Hospitals

Specialty Clinics and Centers

Others

Glioblastoma Region Outlook

Americas
- North America
  - US
  - Canada
- Latin America

Europe
- Western Europe
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East & Africa
- Middle East
- Africa

Available Additional Customizations

Mega Trends in the Market

Glioblastoma Market: Challenges

Intended Audience

Pharmaceutical companies

Contract research manufacturing organizations

Research & development organizations

Academic institutes

Glioblastoma Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions